PD35-07 PROSTATE CANCER RISKS IN MALE BRCA1/2 PATHOGENIC VARIANT CARRIERS
Susan Hiraki, Rachel T. Klein, Megan L. Marshall(St Mark's Hospital), Lisa R. Susswein, Patricia D. Murphy(Newark Beth Israel Medical Center), Lance Grau, Kristen J. Vogel Postula
Cited by 0
Related Papers
The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion.
|PubMed|1989|963
Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing
|Genetics in Medicine|2015|292
Germline Genetic Testing After Cancer Diagnosis
|JAMA|2023|160